China is the second largest pharmaceutical market in the world, forecast to expand from US$108 billion in 2015 to US$167 billion by 2020. Photo: AP

Chinese cancer-drug maker BeiGene in US$1.4 billion tie-up with biotech giant Celgene

The deal will bankroll trials of BeiGene’s oncology medicines in China, while Celgene gets rights to market its anti-tumour therapy outside Asia

Topic |   Mergers & Acquisitions

TOP PICKS

China is the second largest pharmaceutical market in the world, forecast to expand from US$108 billion in 2015 to US$167 billion by 2020. Photo: AP
READ FULL ARTICLE